1[1]Chinetti G, Griglio S, Antonucei M, et al. Activatio n of proliferactor-activated receptors α and γ induces apoptosis of human mon ocyte-derived macrophages. J Biol Chem, 1998,273(40):25575-25580.
2[2]Marx N, Sukhova G, Murphy C, et al. Macrophages in human atheroma conta in PPARγ. Am J Pathol, 1998,153:17-23.
3[3]Nagy L, Tontonoz P, Alvarez J G A, et al. Oxidized LDL regulates macrop hage gene expression through ligand activation of PPARγ. Cell, 1998,93:229-240.
4[4]Tontonoz P, Nagy L, Alvarez J G A, et al. PPARγ promotes monocyte/macr ophage differentiation and uptake of oxidized LDL. Cell, 1998,93:241-252.
5[5]Horn V J, Ishmael J E, Bhattachayya N, et al. Retinoid X receptor (RXR) within the RXR-retinoic acid receptor heterodimer binds its ligand and enhance s retinoid-dependent gene expression. Mol Cell Biol, 1997,17:644-655.
6[6]Calvo D, Coronado D, Suarez Y, et al. Human CD36 is a high affinity rec eptor for the native lipoprotein HDL, LDL and VLDL. J Lipid Res, 1998,39:777-788 .
7[7]Neumann F J, Marx N, Gawaz M, et al. Induction of cytokine expression i n leukocytes by binding of thrombin-stimulated platelet. Circulation, 1997,95:2 387-2394.
8[8]Staels B, Koeng W, Habib A, et al. Activation of human aortic smooth-m uscle cells in inhibited by PPARα but not by PPARγ activators. Nature, 1998,39 3(25):790-793.
9[9]Ricote A M, Grant P J. Vascular homeostasis, adhesion molecules macrova scular disease in non-insulin-dependent diabetes millitus. Diabetic Med,1997,1 4:423-432.
10[10]Saitoh K. Anti-atheromatous effects of fenofibrate, a hypolipidemic d rug: Anti-atheromatous effects are independent of its hypolipidemic effect in c holesterol-fed rabbits. Folia Pharmacol Japan, 1995,106:41-50.
2Fei GZ,Huang YH,Swedenborg J,et al.Oxidised LDL modulates immune-activation by an IL-12 dependent mechanism.Atherosclerosis.2003,169(1):77-85.
3Hulthe J,Fagerberg B.Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines.Arterioscler Thromb Vasc BioL 2002,22(7):1162-7.
